Develop Robust Analytical Methods & Tools in a Phase-Appropriate & Cost-Efficient Manner, to Improve Cell Characterization, Expedite Product Release & Gain Regulatory Approval
Welcome to the 6th Cell Therapy Analytical Development Summit
Demonstrating your cell therapy’s superior safety and efficacy is vital for standing out in a competitive market and attracting investment. Integrating cutting-edge technologies and robust analytical methods is key to showcasing your product's strengths and securing regulatory approval.
Join the 6th Cell Therapy Analytical Development Summit to advance your analytics, accelerate through IND and clinical trials, and achieve regulatory success.
Explore three focused tracks on immunophenotype, cell-based, and molecular assays. Collaborate with industry leaders like Bristol Myers Squibb, Kite Pharma, and Takeda, and gain actionable insights to propel your pipeline forward.
Engage with experts to overcome challenges in potency, product characterization, method validation, release, and scale-up.
Together, let’s elevate the development of potent, safe, and effective cell therapies.
Our Expert Speaker Faculty:
Stephan Krause
Executive Director, Analytical Science & Technology, Cell Therapy Quality, Bristol Myers Squibb
Bristol Myers Squibb